These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31102655)

  • 21. Genome editing in the mammalian brain using the CRISPR-Cas system.
    Nishiyama J
    Neurosci Res; 2019 Apr; 141():4-12. PubMed ID: 30076877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium.
    Pyne ME; Bruder MR; Moo-Young M; Chung DA; Chou CP
    Sci Rep; 2016 May; 6():25666. PubMed ID: 27157668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viral Vectors, Engineered Cells and the CRISPR Revolution.
    DiCarlo JE; Deeconda A; Tsang SH
    Adv Exp Med Biol; 2017; 1016():3-27. PubMed ID: 29130151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review).
    Rodríguez-Rodríguez DR; Ramírez-Solís R; Garza-Elizondo MA; Garza-Rodríguez ML; Barrera-Saldaña HA
    Int J Mol Med; 2019 Apr; 43(4):1559-1574. PubMed ID: 30816503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR-Cas9; an efficient tool for precise plant genome editing.
    Islam W
    Mol Cell Probes; 2018 Jun; 39():47-52. PubMed ID: 29621557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an Efficient Genome Editing Tool in Bacillus licheniformis Using CRISPR-Cas9 Nickase.
    Li K; Cai D; Wang Z; He Z; Chen S
    Appl Environ Microbiol; 2018 Mar; 84(6):. PubMed ID: 29330178
    [No Abstract]   [Full Text] [Related]  

  • 27. Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon.
    Cheng F; Gong L; Zhao D; Yang H; Zhou J; Li M; Xiang H
    J Genet Genomics; 2017 Nov; 44(11):541-548. PubMed ID: 29169919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR: From Prokaryotic Immune Systems to Plant Genome Editing Tools.
    Bandyopadhyay A; Mazumdar S; Yin X; Quick WP
    Adv Exp Med Biol; 2017; 1016():101-120. PubMed ID: 29130156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Transgenic Core Facility's Experience in Genome Editing Revolution.
    Yuan CL; Hu YC
    Adv Exp Med Biol; 2017; 1016():75-90. PubMed ID: 29130154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiplex conditional mutagenesis in zebrafish using the CRISPR/Cas system.
    Yin L; Maddison LA; Chen W
    Methods Cell Biol; 2016; 135():3-17. PubMed ID: 27443918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR-Cas9: from Genome Editing to Cancer Research.
    Chen S; Sun H; Miao K; Deng CX
    Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR-Cas System: The Current and Emerging Translational Landscape.
    Bhokisham N; Laudermilch E; Traeger LL; Bonilla TD; Ruiz-Estevez M; Becker JR
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR/Cas-Based Genome Editing for Human Gut Commensal
    Zheng L; Tan Y; Hu Y; Shen J; Qu Z; Chen X; Ho CL; Leung EL; Zhao W; Dai L
    ACS Synth Biol; 2022 Jan; 11(1):464-472. PubMed ID: 34990118
    [No Abstract]   [Full Text] [Related]  

  • 34. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR/Cas9-Enabled Multiplex Genome Editing and Its Application.
    Minkenberg B; Wheatley M; Yang Y
    Prog Mol Biol Transl Sci; 2017; 149():111-132. PubMed ID: 28712493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenome Editing in the Brain.
    Bashtrykov P; Jeltsch A
    Adv Exp Med Biol; 2017; 978():409-424. PubMed ID: 28523558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inducible CRISPR genome-editing tool: classifications and future trends.
    Dai X; Chen X; Fang Q; Li J; Bai Z
    Crit Rev Biotechnol; 2018 Jun; 38(4):573-586. PubMed ID: 28936886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
    Duroux-Richard I; Giovannangeli C; Apparailly F
    Joint Bone Spine; 2017 Jan; 84(1):1-4. PubMed ID: 27825565
    [No Abstract]   [Full Text] [Related]  

  • 39. Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editing.
    Miyaoka Y; Berman JR; Cooper SB; Mayerl SJ; Chan AH; Zhang B; Karlin-Neumann GA; Conklin BR
    Sci Rep; 2016 Mar; 6():23549. PubMed ID: 27030102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.